Incidence and Characteristics of Non-Hodgkin’s Lymphomas in HCV-Positive Patients with Mixed Cryoglobulinemia

  • Pietro Enrico Pioltelli
  • Giuseppe Monti
  • Maurizio Pietrogrande
  • Massimo Galli


Non-Hodgkin’s lymphomas arise in HCV-positive patients with cryoglobulinemia at a frequency higher than in either the general matched population or in HCV-patients without cryoglobulinemia. The relevance of the cryogenic effect on the response to treatment and on prognosis has been poorly assessed with respect to the characteristics of this patient population, and the typical histological patterns linked to this situation have not been easily identifiable. In recent years, many biological findings have suggested a relevant role of the patient’s genetic background in favoring the malignant evolution of this disease, in which the long-lasting presence of an antigen that induces the production of cryoprecipitating immune complexes drives the expansion of lymphoid tissue in a manner that is unstable and prone to evolve toward a lymphoid malignancy.


Mixed Cryoglobulinemia Splenic Lymphoma General Matched Population Overt Lymphoma Immunoblastic Lymphadenopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Schultz DR, Yunis AA (1975) Immunoblastic lymphadenopathy with mixed cryoglobulinemia. A detailed case study. N Engl J Med 292(1):8–12PubMedCrossRefGoogle Scholar
  2. 2.
    Monteverde A, Rivano MT, Allegra GC et al (1988) Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 79(1):20–25PubMedCrossRefGoogle Scholar
  3. 3.
    Mussini C, Mascia MT, Zanni G et al (1991) A cytomorphological and immunohistochemical study of bone marrow in the diagnosis of essential mixed type II cryoglobulinemia. Haematologica 76(5):389–391PubMedGoogle Scholar
  4. 4.
    Monteverde A, Sabattini E, Poggi S et al (1995) Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a ­monoclonal B-cell proliferation. Leuk Lymphoma 20(1–2):119–124PubMedCrossRefGoogle Scholar
  5. 5.
    Pozzato G, Mazzaro C, Crovatto M et al (1994) Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 84(9):3047–3053PubMedGoogle Scholar
  6. 6.
    Rasul I, Shepherd FA, Kamel-Reid S et al (1999) Detection of occult low-grade b-cell non-Hodgkin’s lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 29(2):543–547PubMedCrossRefGoogle Scholar
  7. 7.
    Rubbia-Brandt L, Bründler MA, Kerl K et al (1999) Primary hepatic diffuse large B-cell lymphoma in a patient with chronic hepatitis C. Am J Surg Pathol 23(9):1124–1130PubMedCrossRefGoogle Scholar
  8. 8.
    Chowla A, Malhi-Chowla N, Chidambaram A et al (1999) Primary hepatic lymphoma in hepatitis C: case report and review of the literature. Am Surg 65(9):881–883PubMedGoogle Scholar
  9. 9.
    Licata A, Pietrosi G, Rizzo A et al (2003) Disseminated non-Hodgkin’s lymphoma and chronic hepatitis C: a case report. Ann Ital Med Int 18(4):246–249PubMedGoogle Scholar
  10. 10.
    Lizardi-Cervera J, Poo JL, Romero-Mora K et al (2006) Hepatitis C virus infection and non-Hodgkin’s lymphoma: a review and case report of nine patient. Ann Hepatol 5(4):257–262PubMedGoogle Scholar
  11. 11.
    Vincent D, Gombert B, Vital A et al (2007) A case of mononeuropathy multiplex with type II cryoglobulinemia, necrotizing vasculitis and low grade B cell lymphoma. Clin Neuropathol 26(1):28–31PubMedGoogle Scholar
  12. 12.
    Krishnan C, Cupp JS, Arber DA et al (2007) Lymphoplasmacytic lymphoma arising in the setting of hepatitis C and mixed cryoglobulinemia. J Clin Oncol 25(27):4312–4314PubMedCrossRefGoogle Scholar
  13. 13.
    Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33(6):355–374PubMedCrossRefGoogle Scholar
  14. 14.
    Machida K, Cheng KT, Pavio N et al (2005) Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 79(13):8079–8089PubMedCrossRefGoogle Scholar
  15. 15.
    Rosa D, Saletti G, De Gregorio E et al (2005) Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 102(51):18544–18549PubMedCrossRefGoogle Scholar
  16. 16.
    Feldmann G, Nischalke HD, Nattermann J et al (2006) Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. Clin Cancer Res 12(15):4491–4498PubMedCrossRefGoogle Scholar
  17. 17.
    Landau DA, Saadoun D, Calabrese LH et al (2007) The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun Rev 6(8):581–587PubMedCrossRefGoogle Scholar
  18. 18.
    Landau DA, Rosenzwajg M, Saadoun D et al (2009) The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders. Ann Rheum Dis 68(3):337–344PubMedCrossRefGoogle Scholar
  19. 19.
    Charles ED, Green RM, Marukian S et al (2008) Clonal expansion of immunoglobulin M + CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 111(3):1344–1356PubMedCrossRefGoogle Scholar
  20. 20.
    De Vita S, De Re V, Gasparotto D et al (2000) Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma. Arthritis Rheum 3(1):94–102CrossRefGoogle Scholar
  21. 21.
    De Vita S, Sansonno D, Dolcetti R et al (1995) Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 86(5):1887–1892PubMedGoogle Scholar
  22. 22.
    Alisi A, Giannini C, Spaziani A et al (2007) Hepatitis C virus core protein enhances B lymphocyte proliferation. Dig Liver Dis 39(Suppl 1):S72–S75PubMedCrossRefGoogle Scholar
  23. 23.
    Fabris M, Quartuccio L, De Re V et al (2008) Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes [in Italian]. Reumatismo 60(1):28–34PubMedGoogle Scholar
  24. 24.
    De Re V, Caggiari L, Monti G et al (2010) HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin’s lymphoma is related to the type II mixed cryoglobulinemia. Tissue Antigens 75(2):127–135, Epub 2009 Dec 9PubMedCrossRefGoogle Scholar
  25. 25.
    Rosas SE, Tomaszewski JE, Feldman HI et al (1999) Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection. Am J Nephrol 19(5):599–604PubMedCrossRefGoogle Scholar
  26. 26.
    Díaz-Peromingo JA, García-Suárez F, Saborido-Froján J et al (2001) Mixed cryoglobulinaemia and B-cell ­lymphoma in the absence of hepatitis C virus infection. Haematologia (Budap) 31(3):225–230CrossRefGoogle Scholar
  27. 27.
    Saadoun D, Sellam J, Ghillani-Dalbin P et al (2006) Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 166(19):2101–2108PubMedCrossRefGoogle Scholar
  28. 28.
    Monti G, Pioltelli P, Saccardo F et al (2005) Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed Cryoglobulinemias. Arch Intern Med 165(1):101–105PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Pietro Enrico Pioltelli
    • 1
  • Giuseppe Monti
    • 2
  • Maurizio Pietrogrande
    • 3
  • Massimo Galli
    • 4
  1. 1.Hematology UnitOspedale San GerardoMonzaItaly
  2. 2.Internal Medicine UnitOspedale di SaronnoSaronnoItaly
  3. 3.Internal Medicine Unit, Policlinico San Marco, Osio SottoUniversity of MilanMilanItaly
  4. 4.Department of Clinical Sciences “Luigi Sacco”, Section of Infectious and Tropical DiseasesUniversità di MilanoMilanItaly

Personalised recommendations